Chinese American Population

768 Words2 Pages

Bicultural Ecology of the Chinese American Population Common Diseases Just like any other society, there exists a broad difference in the indicators and outcomes of health statistics among the Chinese Americans (Lean & Lee, 2012). Different types of health conditions affecting the Chinese Americas all through the United States include; cancer, diabetes, osteoporosis, cardiovascular and hepatitis B. The information derived from the ministry of health shows that cancer causes most deaths among the Chinese Americans (Amill, Serrano, González, & Pérez-Perdomo, 2015). It further indicates that Chinese Americans have the highest cases of both stomach and liver cancer. The data suggests that the Chinese Americans are more vulnerable to cancer-causing …show more content…

For instance, 5.6 % of them have heart disease; congenital heart disease affects 3.8% of them, and 16.1% of them have hypertension. The data indicates that 7.5% of Chinese Americans have diabetes. The likelihood of them developing type-2 diabetes is double that of non-Hispanic whites, even though they have a lower body weight. Based on age, BMI, and sex, Chinese Americans have a prevalence of 60% in contracting diabetes (Chew, Lim, Lee, &Chowbay, 2013). Chinese women in the U.S are more vulnerable to developing osteoporosis. Since the mean intake of important minerals such as calcium, which is an essential nutrient to healthy bones, among Chinese women is half that of Whites (Fan et al., …show more content…

There are two traditional pathways known for metabolism purposes; phase one reaction, which involves oxidation, reduction, and hydrolysis. The phase two results include glucuronidation, acetylation, sulfation, and methylation. However, the arrangements do not conclusively define which drug metabolism reactions take place (Lee, Graeme Fincke, &Ren, 2001). The general purpose of all metabolic reactions is to convert lipophilic drugs into hydrophilic metabolites that are easy to excrete. Chinese Americans exhibit an altered response to most drugs manufactured in the United States due to their broad genetic variation from other ethnic groups. Most clinicians are increasingly aware of this trend (Lee, Graeme Fincke, & Ren, 2001). However, the fast increasing nature of the genetic variants used in drug metabolism affects the metabolizing enzymes, which impacts the therapeutic index of any given drug. The changes as mentioned earlier, may result in alterations in the drug

Open Document